Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 5c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of ($0.12), $0.05 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.07 million versus the consensus estimate of $8.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Cliffwater Private Credit Fund Sees 16% Redemption Requests - Bloomberg
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance